ATE231150T1 - Optisch aktive verbindungen - Google Patents

Optisch aktive verbindungen

Info

Publication number
ATE231150T1
ATE231150T1 AT94102875T AT94102875T ATE231150T1 AT E231150 T1 ATE231150 T1 AT E231150T1 AT 94102875 T AT94102875 T AT 94102875T AT 94102875 T AT94102875 T AT 94102875T AT E231150 T1 ATE231150 T1 AT E231150T1
Authority
AT
Austria
Prior art keywords
diastereoisomer
diastereoisomers
substantially pure
new
optically active
Prior art date
Application number
AT94102875T
Other languages
English (en)
Inventor
Hamish C S Wood
Lilias Rees
Colin James Suckling
Original Assignee
Univ Strathclyde
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10603634&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE231150(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Strathclyde filed Critical Univ Strathclyde
Application granted granted Critical
Publication of ATE231150T1 publication Critical patent/ATE231150T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • C07D475/02—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4
    • C07D475/04—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4 with a nitrogen atom directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Optical Communication System (AREA)
  • Cyclones (AREA)
AT94102875T 1986-09-03 1987-09-03 Optisch aktive verbindungen ATE231150T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868621268A GB8621268D0 (en) 1986-09-03 1986-09-03 Separation of substances

Publications (1)

Publication Number Publication Date
ATE231150T1 true ATE231150T1 (de) 2003-02-15

Family

ID=10603634

Family Applications (3)

Application Number Title Priority Date Filing Date
AT87307803T ATE230746T1 (de) 1986-09-03 1987-09-03 Optisch aktive pteridinderivate
AT02018955T ATE295173T1 (de) 1986-09-03 1987-09-03 Pteridinderivat enthaltende pharmazeutische zusammensetzung
AT94102875T ATE231150T1 (de) 1986-09-03 1987-09-03 Optisch aktive verbindungen

Family Applications Before (2)

Application Number Title Priority Date Filing Date
AT87307803T ATE230746T1 (de) 1986-09-03 1987-09-03 Optisch aktive pteridinderivate
AT02018955T ATE295173T1 (de) 1986-09-03 1987-09-03 Pteridinderivat enthaltende pharmazeutische zusammensetzung

Country Status (10)

Country Link
US (3) US4959472A (de)
EP (3) EP0608002B1 (de)
JP (3) JP2844532B2 (de)
AT (3) ATE230746T1 (de)
AU (1) AU598024B2 (de)
CA (1) CA1339368C (de)
DE (3) DE3752361T2 (de)
ES (3) ES2191669T3 (de)
GB (1) GB8621268D0 (de)
ZA (1) ZA876562B (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5124452A (en) * 1978-07-10 1992-06-23 Bioresearch S.P.A. Process for producing d,1-5-methyltetrahydrofolic acid and its salts
US5223500A (en) * 1977-02-22 1993-06-29 Bioresearch S.P.A. Stable pharmaceutical composition of alkaline or alkaline earth 5-methyl tetrahydrofolate
GB8621268D0 (en) * 1986-09-03 1986-10-08 Univ Strathclyde Separation of substances
CH673459A5 (de) * 1987-05-15 1990-03-15 Eprova Ag
DE3821875C1 (de) * 1988-06-29 1990-02-15 Eprova Ag, Forschungsinstitut, Schaffhausen, Ch
JPH0265787A (ja) * 1988-08-30 1990-03-06 Kyowa Hakko Kogyo Co Ltd Ｌ（‐）‐テトラヒドロ葉酸の製造法
MY106598A (en) * 1988-08-31 1995-06-30 Australian Commercial Res & Development Ltd Compositions and methods for drug delivery and chromatography.
CH676981A5 (de) * 1988-11-11 1991-03-28 Eprova Ag
IT1229517B (it) * 1989-01-31 1991-09-03 Bioresearch Spa Impiego di acido 5-metiltetraidrofolico, di acido 5 formiltetraidrofolico, e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato adatte ad essere impiegate nella terapia dei disordini depressivi e composizioni farmaceutiche relative.
ATE139799T1 (de) * 1989-12-11 1996-07-15 American Cyanamid Co Verfahren zur herstellung von optisch reinen diastereoisomeren von tetrahydrofolatverbindungen
FR2659330B1 (fr) * 1990-03-09 1994-02-11 Sapec Sa Composes diastereoisomeres derivant de l'acide tetrahydrofolique, procede de preparation et utilisation dans la synthese de diastereomeres 6s et 6r de folates reduits.
CH680731A5 (de) * 1990-04-12 1992-10-30 Sapec Fine Chemicals
US5245053A (en) * 1990-05-04 1993-09-14 American Cyanamid Company Substituted 5-(2-(2-aryl-2-hydroxyethyl)-amino)propyl)-1,3-benzodioxoles
US5153309A (en) * 1990-07-27 1992-10-06 The United States Of America As Represented By The Department Of Health And Human Services Process of making tetrahydropteroylpoly-l-glutamic acid derivatives
CH681303A5 (de) * 1991-01-16 1993-02-26 Eprova Ag
ZA923641B (en) * 1991-05-21 1993-02-24 Iaf Biochem Int Processes for the diastereoselective synthesis of nucleosides
DE4136921A1 (de) * 1991-11-11 1993-05-13 Knoll Ag Verfahren zur trennung von 5-methyl-tetrahydrofolsaeure
CH683690A5 (de) * 1991-12-21 1994-04-29 Sapec Fine Chemicals Verfahren zur Herstellung von diastereoisomerenreinen Tetrahydrofolaten.
CH683262A5 (it) * 1992-01-22 1994-02-15 Applied Pharma Res Procedimento per la separazione dei diastereomeri del sale di calcio dell'acido (6(R,S)-N-formiltetraidrofolico).
IT1254635B (it) * 1992-02-20 1995-09-28 Bracco Spa Processo per la separazione degli stereoisomeri dell'acido folinico
US5198547A (en) * 1992-03-16 1993-03-30 South Alabama Medical Science Foundation, Usa Process for N5-formylating tetrahydropteridines
CH684644A5 (de) * 1992-07-13 1994-11-15 Eprova Ag 5,10-Methylentetrahydrofolsäure-Cyclodextrin-Einschlussverbindungen.
US5698693A (en) * 1992-11-16 1997-12-16 The United States Of America As Represented By The Department Of Health And Human Services Process of separating the diastereomers of (6R,6S) -5,6,7,8-tetrahydrofolic acid derivatives
CH686369A5 (de) * 1994-05-09 1996-03-15 Eprova Ag Stabile kristalline (6S)- und (6R)-Tetrahydrofolseure.
RU2109015C1 (ru) * 1993-07-16 1998-04-20 Эй Си Эс Добфар С.п.А. Способ получения (6s)-изомеров производных фолиевой кислоты
US5498719A (en) * 1994-01-31 1996-03-12 The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services Diastereoselective process leading to a key intermediate for the preparation of fluorinated reverse transcriptase inhibitors
US5550128A (en) * 1994-09-09 1996-08-27 Nair; Madhavan G. Enantiomers of gamma methylene 10-deaza aminopterin and process for preparing the same
US6162914A (en) * 1998-04-24 2000-12-19 Cerbios-Pharma S.A. Process for the reduction of pterins
JP3330903B2 (ja) * 1999-08-05 2002-10-07 ダイセル化学工業株式会社 フォトレジスト用高分子化合物及びフォトレジスト用樹脂組成物
US20040266732A1 (en) * 2002-09-20 2004-12-30 Jorge Galvez Therapeutic agents, methods, and treatments
EP1751312A4 (de) * 2004-05-21 2010-01-27 Univ Duke Polymorphismus bei tryptophanhydroxylase-2 als steuerung der gehirnserotoninsynthese
KR20060051135A (ko) * 2004-09-15 2006-05-19 니프로 가부시키가이샤 안정화된 주사용 수용액 제재
JP4956942B2 (ja) * 2004-09-15 2012-06-20 ニプロ株式会社 安定化された注射用水溶液製剤
CN101668719B (zh) * 2007-02-07 2013-01-02 日立金属株式会社 低损耗铁氧体及使用其的电子零件
WO2010057515A1 (en) * 2008-11-21 2010-05-27 Synthon B.V. Levocetirizine by menthyl intermediate
WO2012054815A1 (en) 2010-10-22 2012-04-26 Duke University Slow-release formulations of 5-hydroxytryptophan as an adjunct to pro-serotonergic therapies
CN102329318B (zh) * 2011-10-20 2013-07-10 浙江圣达药业有限公司 一种高纯度四氢叶酸的制备方法
CN105399747A (zh) * 2015-10-30 2016-03-16 天津药物研究院药业有限责任公司 左旋5，10-亚甲基四氢叶酸的制备方法
CN114516874A (zh) * 2022-03-11 2022-05-20 国药一心制药有限公司 一种甲氨蝶呤新晶型及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2688018A (en) * 1952-06-28 1954-08-31 American Cyanamid Co Method of preparing alkaline earth metal salts of 1-leucovorin
GB1572137A (en) * 1977-02-22 1980-07-23 Bioresearch Sas Del Dr Livio C Stable compositions for therapeutic use based on d,1-5-methyltetrahydrofolic acid and its salts
GB1560372A (en) * 1977-03-21 1980-02-06 Wellcome Found Preparation of calcium folinate
FI812775L (fi) * 1980-09-12 1982-03-13 Farmos Oy Foerfarande foer framstaellning av n-/4-/(2,4-diamino-6-pteridinyl)-metyl/metylamino/benzoyl/glutaminsyra och derivat daerav
AU2816384A (en) * 1983-04-11 1984-11-07 University Of South Alabama Regulation of enzymes which utilize tetrahydrobiopterin or tetrahydrofolate cofactors with 6,6-disubstituted- tetrahydropteridines
US4665176A (en) * 1984-10-23 1987-05-12 Mitsui Toatsu Chemicals, Incorporated Process for the preparation of 5,6,7,8-tetrahydrofolic acid
GB8621268D0 (en) * 1986-09-03 1986-10-08 Univ Strathclyde Separation of substances
CH673459A5 (de) * 1987-05-15 1990-03-15 Eprova Ag
CH676981A5 (de) * 1988-11-11 1991-03-28 Eprova Ag

Also Published As

Publication number Publication date
US4959472A (en) 1990-09-25
ES2241933T3 (es) 2005-11-01
EP0266042A3 (de) 1989-11-15
EP0608002B1 (de) 2003-01-15
JPS63115880A (ja) 1988-05-20
DE3752384D1 (de) 2005-06-16
JP2844532B2 (ja) 1999-01-06
DE3752362D1 (de) 2003-02-20
ES2189782T3 (es) 2003-07-16
AU598024B2 (en) 1990-06-14
CA1339368C (en) 1997-08-26
AU7777587A (en) 1988-03-31
DE3752361D1 (de) 2003-02-13
EP0266042A2 (de) 1988-05-04
ATE230746T1 (de) 2003-01-15
DE3752384T2 (de) 2006-01-19
EP1275393A1 (de) 2003-01-15
DE3752362T2 (de) 2003-11-20
EP0608002A1 (de) 1994-07-27
US6500829B1 (en) 2002-12-31
US20020198212A1 (en) 2002-12-26
EP1275393B1 (de) 2005-05-11
JPH11106342A (ja) 1999-04-20
ES2191669T3 (es) 2003-09-16
ATE295173T1 (de) 2005-05-15
JP2000136135A (ja) 2000-05-16
DE3752361T2 (de) 2003-10-30
GB8621268D0 (en) 1986-10-08
EP0266042B1 (de) 2003-01-08
ZA876562B (en) 1989-06-28
US6849628B2 (en) 2005-02-01

Similar Documents

Publication Publication Date Title
DE3752362D1 (de) Optisch aktive Verbindungen
CA1258859A (en) CARBOSTYRILE DERIVATIVE, AND ITS PREPARATION
UA27749C2 (uk) Заміщені циклопропіламіно-1,3,5-триазини, їх оптичні ізомери, рацемічні суміші чи їх солі приєднання нетоксичних фармацевтично прийнятних кислот, що мають фармакологічну активність, спосіб їх одержання (варіанти) та фармацевтична композиція на їх основі
CA2018692A1 (fr) Procede de preparation de l'acide ascorbique
FI951414L (fi) Menetelmä epäpuhtaan klavulaanihapon puhdistamiseksi
RU93049997A (ru) Производные метилен-бис-фосфоновой кислоты, способ их получения, фармацевтическая композиция
IE881837L (en) Process
ATE49969T1 (de) Verfahren zur herstellung von pteridinderivaten.
CS412388A2 (en) Method of 7-piperazino-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxyl acid's derivatives production
CS884386A2 (en) Zpusob vyroby novych soli aryloxypropanolaminu s kyselinou difenyloctovou
PL266361A1 (en) Method for manufacturing new tetrahydrobenyotiazole derivatives
MX9803887A (es) Produccion de una sal de acido clavulanico.
FI890678A0 (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisten 1,3-dioksaanialkeenihappojohdannaisten valmistamiseksi
ES2003994A6 (es) Procedimiento de preparacion de nuevas 2-cloro-12-(3-dimetilamino-2-metilpropil)-12h-dibenzo(d,g) (i,3,6) dioxazocinas opticamente activas y de sus sales de adicion acidas farmaceuticamente aceptables
TNSN86165A1 (fr) Nouveaux ortho-anisamides, leur procede d'obtention et leurs applications therapeutiques
IE882357L (en) Benzoxazine derivatives
ES2023758A6 (es) Metodo para preparar derivados de furo (3, 4-c) pirinina no racemicos.
AU2601088A (en) Hypoglycaemic peptides
BG47345A3 (en) Method for preparing of dialkyloxalacetates
ES8405781A1 (es) Metodo de obtencion de derivados n-metilcarbamaticos utiles para insecticidas.
DZ1366A1 (fr) Nouveaux dérivés de la méthoxycarbonyl-2 n,n'-di-(triméthoxybenzoyle) pipérazine, ainsi que leur procédé de préparation.
GB1387769A (en) Butenoic acid derivatives and a process for the manufacture thereof
JPS53112868A (en) Production of thienylacetic acid derivative
KR890003725A (ko) 아민유도체 및 이의 염, 이의 제조방법 및 이를 함유하는 궤양치료제
PL262300A1 (en) Process for preparing novel derivatives of l-2,3-diaminopropanic acid of tripeptides structure

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0608002

Country of ref document: EP

RZN Patent revoked
RZN Patent revoked